The Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Cellular Senescence of Cultivated Human Corneal Endothelial Cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose We have begun a clinical trial of a cell-based therapy for corneal endothelial dysfunction in Japan. The purpose of this study was to investigate the usefulness of a p38 MAPK inhibitor for prevention cellular senescence in cultivated human corneal endothelial cells (HCECs). Methods HCECs of 10 donor corneas were divided and cultured with or without SB203580 (a p38 MAPK inhibitor). Cell density and morphology were evaluated by phase-contrast microscopy. Expression of function-related proteins was examined by immunofluorescent staining. Cellular senescence was evaluated by SA-β-gal staining and Western blotting for p16 and p21. Senescence-associated factors were evaluated by membrane blotting array, quantitative PCR, and ELISA. Results Phase-contrast microscopy showed a significantly higher cell density for HCECs cultured with SB203580 than without SB203580 (2623 ± 657 cells/mm2 and 1752 ± 628 cells/mm2, respectively). The HCECs cultured with SB203580 maintained a hexagonal morphology and expressed ZO-1, N-cadherin, and Na+/K+-ATPase in the plasma membrane, whereas the control HCECs showed an altered staining pattern for these marker proteins. HCECs cultured without SB203580 showed high positive SA-β-gal staining, a low nuclear/cytoplasm ratio, and expression of p16 and p21. IL-6, IL-8, CCL2, and CXCL1 were observed at high levels in low cell density HCECs cultured without SB203580. Conclusions Activation of p38 MAPK signaling due to culture stress might be a causative…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p38 inhibition has been shown to be beneficial in the successful maintenance of human corneal endothelial cell cultures, enhancing proliferation and allowing colony expansion [ 149 ] while minimizing cellular senescence [ 150 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [150]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“SA-b-gal is the biomarker most frequently used to show upregulation of the lysosome mass induced by the loss of capabilities to respond to cellular damage and stress.(31,32) However, the sole use of SA-b-gal as marker often yields false-positive results, necessitating the use of a combination of several markers.”
BackgroundThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“The secreted factors include inflammatory mediators, growth factors, and detached cell surface molecules, but SASP is cell-type and senescence-stage dependent.(41,42) Here, we demonstrated that IL-6, IL-8, CCL2, and CXCL1 were expressed at high levels in low cell density HCECs.”
BackgroundTargeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788 · cited 1×
“Signaling by p38 MAPK is associated with various cellular activities, such as cell proliferation, differentiation, migration, and apoptosis.(19) In addition, p38 MAPK plays an important role in cellular senescence.”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Tonnel, A. (1991) · doi:10.1111/j.1365-2222.1991.tb00866.x · Cited by 1,126
Descemet-Stripping Automated Endothelial Keratoplasty
Gorovoy, M. S. (2006) · Cornea · doi:10.1097/01.ico.0000214224.90743.01 · Cited by 869
Toussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713
Cited by
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“Several pathways of investigation suggest that senescent primary human CD8+ T cells use anaerobic glycolysis to generate energy for effector functions and that p38 mitogen-activated protein kinase (p38 MAPK) blockade may reverse senescence via the mTOR-independent pathway (116).”
BackgroundInjection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
Kinoshita, S., Koizumi, N., Ueno, M., Okumura, N., Imai, K., Tanaka, H., Yamamoto, Y., Nakamura, T., Inatomi, T., Bush, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712770 · Cited by 542
Self-citationSenescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497
Cellular senescence: Molecular mechanisms and pathogenicity
Wei, W., & Ji, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26956 · Cited by 210
Han, J., Wu, J., & Silke, J. (2020) · F1000Research · doi:10.12688/f1000research.22092.1 · Cited by 174
The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Sun, Y., Wang, X., Liu, T., Zhu, X., & Pan, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00815-5 · Cited by 168
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Indeed, p38 inhibition has been shown to be beneficial in the successful maintenance of human corneal endothelial cell cultures, enhancing proliferation and allowing colony expansion [149] while minimizing cellular senescence [150].”
BackgroundKhavinson, V., Linkova, N., Dyatlova, A., Kantemirova, R., & Kozlov, K. (2022) · Cells · doi:10.3390/cells12010106 · Cited by 62
Phenotypic and functional characterization of corneal endothelial cells during in vitro expansion
Frausto, R. F., Swamy, V. S., Peh, G. S. L., Boere, P. M., Hanser, E. M., Chung, D. D., George, B. L., Morselli, M., Kao, L., Azimov, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64311-x · Cited by 76
Yazu, H., Yamaguchi, T., Aketa, N., Higa, K., Suzuki, T., Yagi-Yaguchi, Y., Satake, Y., Abe, T., Tsubota, K., & Shimazaki, J. (2018) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.17-23049 · Cited by 52
The role of nitric oxide in ocular surface physiology and pathophysiology.
Tummanapalli, S., Kuppusamy, R., Yeo, J. H., Kumar, N., New, E., & Willcox, M. D. P. (2021) · The ocular surface · doi:10.1016/j.jtos.2021.04.007 · Cited by 38
Regeneration of the Corneal Endothelium
Okumura, N., & Koizumi, N. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1700529 · Cited by 35
“high positive SA-β-gal staining, a low nuclear/cytoplasm ratio, expression of p16 and p21, and a senescence-associated secretory phenotype (SASP).(75) We found that culture stress activates”
BackgroundSelf-citationYan, Y., Yu, H.-Y., Sun, L.-Y., Liu, H.-R., Wang, C., Wei, X., Song, F., Li, H.-L., Ge, H., Qian, H., et al. (2019) · Aging · doi:10.18632/aging.101943 · Cited by 35
“Inhibition of p38 MAPK decreased p16 and p21 levels in senescent cells [65], and may delay the progression of H2O2-induced opacification of lenses [94].”
BackgroundZhou, H., Khan, D., Hussain, S. M., Gerdes, N., Hagenbeck, C., Rana, M., Cornelius, J., & Muhammad, S. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00366-7 · Cited by 34
“Previous studies have shown that inhibiting P38 activation can subdue cellular senescence [48].”
BackgroundOridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells.
Yasuda, S., Horinaka, M., Iizumi, Y., Goi, W., Sukeno, M., & Sakai, T. (2021) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2021.12.098 · Cited by 34
Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation
Nakahara, M., Okumura, N., Nakano, S., & Koizumi, N. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24394 · Cited by 30
Self-citationKe, H., Zhang, X.-J., Liang, S., Zhou, C., Hu, Y., Huang, Q., & Wu, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118421 · Cited by 30
Ex vivo expansion and characterization of human corneal endothelium for transplantation: a review
Smeringaiova, I., Utheim, T. P., & Jirsová, K. (2021) · Stem cell research & therapeutics · doi:10.1186/s13287-021-02611-3 · Cited by 29
Mitochondria as a Platform for Dictating the Cell Fate of Cultured Human Corneal Endothelial Cells
Numa, K., Ueno, M., Fujita, T., Ueda, K., Hiramoto, N., Mukai, A., Tokuda, Y., Nakano, M., Sotozono, C., Kinoshita, S., et al. (2020) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.61.14.10 · Cited by 22
Potential role of cellular senescence in pulmonary arterial hypertension
Liu, L.-M., Wei, Y.-Q., Giunta, S., He, Q.-H., & Xia, S.-J. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13696 · Cited by 21
Senescence of alveolar stem cells drives progressive pulmonary fibrosisPreprint
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G.-L., Soukiasian, H., David, G., Weigt, S., Belperio, J., et al. (2019) · bioRxiv · doi:10.1101/820175 · Cited by 21
Corneal storage methods: considerations and impact on surgical outcomes
Wójcik, G., Ferrari, S., Romano, V., Ponzin, D., Ahmad, S., & Parekh, M. (2020) · Expert Review of Ophthalmology · doi:10.1080/17469899.2021.1829476 · Cited by 19
“Therapies involving Rho kinase (ROCK) [65] and p38 Mitogen-Activated Protein Kinase (MAPK) [66] have been reported.”
BackgroundMetabolites Interrogation in Cell Fate Decision of Cultured Human Corneal Endothelial Cells
Hamuro, J., Numa, K., Fujita, T., Toda, M., Ueda, K., Tokuda, Y., Mukai, A., Nakano, M., Ueno, M., Kinoshita, S., et al. (2020) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.61.2.10 · Cited by 18
mTOR Inhibitor Rapalink-1 Prevents Ethanol-Induced Senescence in Endothelial Cells
Zhou, H., Li, X., Rana, M., Cornelius, J., Khan, D., & Muhammad, S. (2023) · Cells · doi:10.3390/cells12222609 · Cited by 17
“Blocking NF-κ B, MAPKs, and mTOR could inhibit cellular senescence and SASP and increase life span [15–19].”
BackgroundZhou, H., Khan, D., Gerdes, N., Hagenbeck, C., Rana, M., Cornelius, J. F., & Muhammad, S. (2023) · Antioxidants · doi:10.3390/antiox12040960 · Cited by 22
Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture
Aouimeur, I., Sagnial, T., Coulomb, L., Maurin, C., Thomas, J., Forestier, P., Ninotta, S., Perrache, C., Forest, F., Gain, P., et al. (2023) · Cells · doi:10.3390/cells12121624 · Cited by 16
“SB203580 was reported for its protection of CECs’ barrier function in vitro and ex vivo [79,80] and its numerous beneficial effects on hCEC culture through antisenescence mechanisms [38].”
BackgroundInfluentialCorneal endothelial cell therapy: feasibility of cell culture from corneas stored in organ culture
He, Z.-G., Okumura, N., Sato, M., Komori, Y., Nakahara, M., Gain, P., Koizumi, N., & Thuret, G. (2021) · Cell and Tissue Banking · doi:10.1007/s10561-021-09918-8 · Cited by 15
“Although our Japanese research group cultured HCECs for clinical trial using multiple culture techniques (Okumura et al. 2020), the culture has been challenging due to tendency of HCECs to acquire mesenchymal and senescent phenotypes (Nakahara et al. 2013; Hongo et al. 2017).”
BackgroundInfluentialSelf-citationP38-Mediated Cellular Senescence in Conjunctivochalasis Fibroblasts.
Xiang, M.-H., Mo, L., Zhan, Y., Wen, H., Zhou, H.-M., & Miao, W.-H. (2019) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.19-27617 · Cited by 13
Feasibility of a cryopreservation of cultured human corneal endothelial cells
Okumura, N., Kagami, T., Watanabe, K., Kadoya, S., Sato, M., & Koizumi, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218431 · Cited by 13
Self-citationChen, L., Chen, Z., Hao, S.-J., Chen, R.-R., Chen, S., Gu, Y.-Z., Sheng, F., Zhao, W., Lu, B., Wu, Y.-H., et al. (2024) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167265 · Cited by 11
In Vitro Expansion of Corneal Endothelial Cells for Clinical Application: Current Update.
Hazra, S., Sneha, I. V., Chaurasia, S., & Ramachandran, C. (2022) · Cornea · doi:10.1097/ico.0000000000003080 · Cited by 11
The Ageing Immune System and Health
Bueno, V., Lord, J., & Jackson, T. (2017) · doi:10.1007/978-3-319-43365-3 · Cited by 10
Cantero‐Fortiz, Y., Butler, C., Montalbán, X., & Boada, M. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1805691 · Cited by 9
“Similarly, JAK inhibitors such as ruxolitinib and p38 MAPK inhibitors have demonstrated efficacy in downregulating the SASP and restoring tissue homeostasis (Riessland et al., 2024; Riessland et al., 2024; Xu et al., 2015; Hongo et al., 2017).”
Cosentino, A., Agafonova, A., Cavallaro, L., Musumeci, R. E., Prinzi, C., Lombardo, C., Cambria, M. T., Anfuso, C. D., & Lupo, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030916 · Cited by 8
“All the samples were run in triplicate and normalized by the expression of the endogenous 18S rRNA gene.”
Yang, G. N., Sun, Y., Roberts, P. K., Moka, H. A., Sung, M. K., Gardner-Russell, J., Wazan, L. E., Toussaint, B., Kumar, S., Machin, H. M., et al. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101286 · Cited by 6
Onishi, T., Yuasa, T., Ueda, N., Miyadai, K., Tourtas, T., Schlötzer-Schrehardt, U., Kruse, F., Koizumi, N., & Okumura, N. (2025) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.66.11.63 · Cited by 5
“…previous evidence that p38 MAPK inhibition not only abrogates apoptotic processes but may also stimulate corneal endothelial cell proliferation, 46,47 indicating that this treatment could potentially address both the pathological cell loss and regenerative capacity issues that are hallmarks of…”
Self-citationLeu, S., Wu, K. L. H., Lee, W.-C., Tain, Y., & Chan, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102429 · Cited by 5
“Another study also indicated that inhibition of MAPK-p38 increases the proliferation of EPCs [43] as well as counteract senescence in corneal endothelial cells [45].”
BackgroundCell Based Therapy for Corneal Endothelial Regeneration
Koizumi, N., & Okumura, N. (2019) · Essentials in Ophthalmology · doi:10.1007/978-3-030-01304-2_30 · Cited by 5
Self-citationZhou, H., Khan, D., Hussain, S. M., Gerdes, N., Hagenbeck, C., Rana, M., Cornelius, J., & Muhammad, S. (2023) · bioRxiv · doi:10.1101/2023.08.04.552075 · Cited by 3
Bioengineering of Human Corneal Endothelial Cells from Single- to Four-Dimensional Cultures
Tsao, Y.-T., Cheng, C.-M., Wu, W.-C., & Chen, H.-C. (2020) · Current Ophthalmology Reports · doi:10.1007/s40135-020-00244-y · Cited by 3
Chen, T., He, X., Chen, X., Zhang, W., Li, B., Chu, C., Lv, G., & Chen, S. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121233 · Cited by 3
Okumura, N., Kobayashi, K., Ishida, N., Kagami, T., Hiwa, S., Hiroyasu, T., & Koizumi, N. (2018) · Cornea · doi:10.1097/ico.0000000000001757 · Cited by 2
Self-citationYoung cardiac telocyte-derived exosomes rejuvenate aging hearts in rats
Lv, L., Zhu, Y., Chen, Y.-J., Zheng, X., Huang, R., Zhao, H., Yuan, Z.-Q., Feng, S., Qi, X.-F., Chen, Y.-L., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1824533 · Cited by 1
“The activation of p38 MAPK signaling induces cellular senescence (Iwasa et al., 2003; Freund et al., 2011; He et al., 2020; Hongo et al., 2017; Sreedhar et al., 2016), and the activation of the antioxidant activity of vitamin C plays an important role in preventing senescence (Massip et al., 2009;…”
Galangin Mitigates PM2.5-Induced Endoplasmic Reticulum Stress and Senescence in HaCaT Keratinocytes
Herath, H., Piao, M., Kang, K., Fernando, P., Senavirathna, H. M. M. M., Kim, E., Lee, M.-H., Chae, S., & Hyun, J.-W. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05327-9
“P38 MAPK has been shown to induce senescence and the senescence-associated secretory phenotype (SASP) in different cells [26, 27].”
Okumura, N., & Koizumi, N. (2020) · doi:10.1080/17469899.2020.1811088
Self-citationJiang, A., Mao, L., Duan, S., Zhang, Y., Liu, X., Cui, W., Sang, Y., & Huang, G. (2020) · doi:10.21203/rs.3.rs-23760/v1
“As experimental and clinical evidence has shown, Fuchs endothelial dystrophy (FED), chronic corneal allograft failure, and cell density decreases when cells are cultured; in other words, cells exhibit characteristics of senescence.[9, 12, 30] The characteristics of cellular senescence include a senescencelike morpholo…”
ResultCultivated Cells in the Treatment of Corneal Diseases
Kinoshita, S., & Ueno, M. (2019) · Foundations of Corneal Disease · doi:10.1007/978-3-030-25335-6_18
Metadata
- Authors
- Hongo, A., Okumura, N., Nakahara, M., Kay, E. P., & Koizumi, N.
- Affiliations
- Doshisha University (JP)
- Corresponding author
- Koizumi, Noriko
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2017-07-05
- Volume
- 58
- Issue
- 9
- Pages
- 3325
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2725931124
- Cited by
- 53
- References
- 43
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 4 · 2020: 8 · 2019: 8 · 2018: 7
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Ophthalmology › Corneal Surgery and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
- Keywords
- p38 MAPK inhibitor, SB203580, cellular senescence, human corneal endothelial cells, corneal endothelial dysfunction, cell therapy, p16, p21, ZO-1, N-cadherin, Na+/K+-ATPase, corneal tissue engineering
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Cells, Cultured, Endothelium, Corneal, Humans, Imidazoles, Interleukins, Pyridines, Biomarkers, Cadherins, Cellular Senescence, Protein Serine-Threonine Kinases, Chemokines, Endothelial Cells, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.